In July 2020, remimazolam besylate (manufacturer: Byfavo) was accepted from the FDA with the induction and maintenance of procedural sedation in adults undergoing processes lasting thirty minutes or significantly less. While it is exceptional that an overdose of benzodiazepines by itself could be lethal, when combined with other drugs https://federicon158bks1.blogdosaga.com/profile